1. Home
  2. GKOS vs ASLE Comparison

GKOS vs ASLE Comparison

Compare GKOS & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$113.67

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo AerSale Corporation

ASLE

AerSale Corporation

HOLD

Current Price

$6.92

Market Cap

290.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
ASLE
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
290.0M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
ASLE
Price
$113.67
$6.92
Analyst Decision
Strong Buy
Hold
Analyst Count
13
2
Target Price
$123.62
$7.00
AVG Volume (30 Days)
877.3K
372.4K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.11
Revenue
$469,820,000.00
$339,090,000.00
Revenue This Year
$31.15
$1.35
Revenue Next Year
$24.15
$19.09
P/E Ratio
N/A
$61.85
Revenue Growth
30.38
N/A
52 Week Low
$73.16
$5.56
52 Week High
$163.71
$9.12

Technical Indicators

Market Signals
Indicator
GKOS
ASLE
Relative Strength Index (RSI) 73.39 56.85
Support Level $105.88 $6.81
Resistance Level $110.87 $7.06
Average True Range (ATR) 3.17 0.17
MACD -0.02 0.07
Stochastic Oscillator 73.91 74.36

Price Performance

Historical Comparison
GKOS
ASLE

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ASLE AerSale Corporation

AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.

Share on Social Networks: